I-Mab ADR (NASDAQ: IMAB): The Best-Of-Breed For Investing?
Morgan Stanley & Co. LLC recently announced the acquisition of new stake in I-Mab ADR (NASDAQ:IMAB). The institutional investor has increased its shareholding in the Healthcare company by 123.04% to 0.99 million shares with purchase of 0.54 million shares. This fresh investment now brings its stake to 1.18% valued currently at $1.54 million. In addition, […]
